Sofiva GenomicsLtd Salute del bilancio
Salute finanziaria criteri di controllo 6/6
Sofiva GenomicsLtd has a total shareholder equity of NT$640.7M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$775.8M and NT$135.1M respectively. Sofiva GenomicsLtd's EBIT is NT$2.2M making its interest coverage ratio -9.4. It has cash and short-term investments of NT$123.4M.
Informazioni chiave
0%
Rapporto debito/patrimonio netto
NT$0
Debito
| Indice di copertura degli interessi | -9.4x |
| Contanti | NT$123.42m |
| Patrimonio netto | NT$640.72m |
| Totale passività | NT$135.13m |
| Totale attività | NT$775.84m |
Aggiornamenti recenti sulla salute finanziaria
Nessun aggiornamento
Recent updates
Some Investors May Be Worried About Sofiva GenomicsLtd's (GTSM:6615) Returns On Capital
Apr 14
Estimating The Fair Value Of Sofiva Genomics Co.,Ltd. (GTSM:6615)
Mar 18Sofiva Genomics Co.,Ltd. (GTSM:6615) Investors Should Think About This Before Buying It For Its Dividend
Feb 24Should Weakness in Sofiva Genomics Co.,Ltd.'s (GTSM:6615) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Jan 27Our Take On The Returns On Capital At Sofiva GenomicsLtd (GTSM:6615)
Jan 07
A Look At The Intrinsic Value Of Sofiva Genomics Co.,Ltd. (GTSM:6615)
Dec 15Read This Before Buying Sofiva Genomics Co.,Ltd. (GTSM:6615) For Its Dividend
Nov 24Analisi della posizione finanziaria
Passività a breve termine: 6615's short term assets (NT$281.0M) exceed its short term liabilities (NT$89.6M).
Passività a lungo termine: 6615's short term assets (NT$281.0M) exceed its long term liabilities (NT$45.6M).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: 6615 is debt free.
Riduzione del debito: 6615 had no debt 5 years ago.
Copertura del debito: 6615 has no debt, therefore it does not need to be covered by operating cash flow.
Copertura degli interessi: 6615 has no debt, therefore coverage of interest payments is not a concern.